Rozenshtraukh L V, Kaverina E P, Aniukhovskiĭ E P, Dremin S A, Beloshapko G G
Kardiologiia. 1982;22(6):72-8.
Diethylamine analogue of ethmozine (DAA ethmozine) administered intravenously in the doses of 0.5-1 mg/kg exerts marked antiarrhythmic effect both experimentally and clinically, slight effect on the arterial pressure and myocardial contractility and led to insignificant and to statistically insignificant depression of automatism of the sinus node and on the fibres of the conductive system. DAA ethmozine enhanced the duration of the refractory periods of atriae and of the atrio-ventricular node by 20-30%, increased the time of stimulation conduction at all the levels of the conductive system of the heart. Sensitivity of the rapid sodium channels to DAA ethmozine exceeded by one order their sensitivity to ethmozine proper. The sum total of the results and also the preliminary data on the high antiarrhythmic activity of DAA ethmozine justifies the conclusion that this drug may prove to be effective in the treatment of cardiac arrhythmias.
乙胺碘呋酮的二乙胺类似物(DAA乙胺碘呋酮)以0.5 - 1毫克/千克的剂量静脉注射,在实验和临床中均发挥显著的抗心律失常作用,对动脉血压和心肌收缩力影响轻微,且导致窦房结及传导系统纤维的自律性出现不显著以及统计学上无显著意义的抑制。DAA乙胺碘呋酮使心房和房室结的不应期时长延长20 - 30%,增加了心脏传导系统各水平的刺激传导时间。快速钠通道对DAA乙胺碘呋酮的敏感性比其对乙胺碘呋酮本身的敏感性高一个数量级。这些结果的总和以及关于DAA乙胺碘呋酮高抗心律失常活性的初步数据证明了这样一个结论,即这种药物可能被证明对治疗心律失常有效。